Qube Research & Technologies (QRT)
MYGN icon

Qube Research & Technologies (QRT)’s Myriad Genetics MYGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.61M Buy
1,690,461
+817,335
+94% +$4.26M 0.01% 1445
2025
Q4 		$5.37M Sell
873,126
-313,381
-26% -$2.27M 0.01% 1727
2025
Q3 		$8.58M Sell
1,186,507
-865,081
-42% -$5.14M 0.01% 1423
2025
Q2 		$10.9M Buy
2,051,588
+633,439
+45% +$3.74M 0.02% 1238
2025
Q1 		$12.6M Buy
1,418,149
+416,776
+42% +$5.01M 0.02% 990
2024
Q4 		$13.7M Buy
1,001,373
+492,749
+97% +$9.09M 0.02% 907
2024
Q3 		$13.9M Buy
508,624
+437,847
+619% +$11.9M 0.03% 836
2024
Q2 		$1.73M Buy
+70,777
New +$1.55M ﹤0.01% 1698
2024
Q1 		– Sell
-19,070
Closed -$365K – 4737
2023
Q4 		$365K Sell
19,070
-112,483
-86% -$1.95M ﹤0.01% 2467
2023
Q3 		$2.11M Buy
131,553
+113,000
+609% +$2.15M 0.01% 1355
2023
Q2 		$430K Buy
+18,553
New +$405K ﹤0.01% 1553
2022
Q3 		– Sell
-18,025
Closed -$328K – 2832
2022
Q2 		$328K Buy
+18,025
New +$374K ﹤0.01% 1558

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return